The Piromelatine Study for adults with memory problems
February 12, 2016
Steven Potkin, MD
UC Irvine Medical Center in Orange
The Piromelatine study will test the safety and effectiveness of an investigational drug against a placebo (a substance that looks like the study drug but does not contain the active ingredient) in patients with mild dementia due to Alzheimer’s disease.
You are eligible to participate in this study if you:
- Are 60 to 85 years of age
- Have mild probable Alzheimer’s disease
- Have a study partner who you have frequent contact with (stays under the same roof as you at least 3 nights a week) who is willing to accompany you to a few study visits who will communicate changes in your health to the study staff over the period of this study
- Are willing to undergo all study procedures at the study center over the study period
- Agree to a minimum 2-hour daily light exposure requirement
Once enrolled, participants will have five study visits to the clinic and weekly telephone calls in between each visit. Your participation in this study is expected to last up to about 28 weeks.
Total compensation for completing the study as a subject is up to $450 over the study period.